hyaluronoglucosaminidase has been researched along with Heart Failure in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (88.89) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chowdhury, B; Dolinsky, VW; Hemming, R; Liu, M; Triggs-Raine, B; Xiang, B | 1 |
MARTIN, G | 1 |
JUHLIN, L | 1 |
SALTER, WT | 1 |
IVANYI, J; KELEMEN, E; MAJOROS, M | 1 |
Cadigan, PJ; De Giovanni, J; Flint, EJ; Lamb, P; Pentecost, BL | 1 |
Opolski, G; Zochowski, RJ | 1 |
1 trial(s) available for hyaluronoglucosaminidase and Heart Failure
Article | Year |
---|---|
Effect of GL enzyme (a highly purified form of hyaluronidase) on mortality after myocardial infarction.
Topics: Clinical Trials as Topic; Double-Blind Method; Female; Heart Failure; Humans; Hyaluronoglucosaminidase; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Prospective Studies | 1982 |
8 other study(ies) available for hyaluronoglucosaminidase and Heart Failure
Article | Year |
---|---|
Hyaluronidase 2 Deficiency Causes Increased Mesenchymal Cells, Congenital Heart Defects, and Heart Failure.
Topics: Animals; Cardiomegaly; Cell Proliferation; Disease Progression; Endothelial Cells; Epithelial-Mesenchymal Transition; Fibrosis; Genetic Predisposition to Disease; GPI-Linked Proteins; Heart Defects, Congenital; Heart Failure; Heart Valve Diseases; Hyaluronic Acid; Hyaluronoglucosaminidase; Mesenchymal Stem Cells; Mice, Inbred C57BL; Mice, Knockout; Myocardial Contraction; Phenotype; Stroke Volume; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left | 2017 |
HYALURONIDASE for chronic limb oedema.
Topics: Disease; Edema; Heart Failure; Humans; Hyaluronoglucosaminidase; Leg | 1952 |
[Hyaluronidase drainage with kinetin (Schering), a new method for control of cardiac edema].
Topics: Body Fluids; Drainage; Edema, Cardiac; Heart Failure; Hyaluronoglucosaminidase; Kinetin | 1953 |
Diffusion of bacterial and testicular hyaluronidase in dermal connective tissue.
Topics: Administration, Cutaneous; Connective Tissue; Diffusion; Heart Failure; Humans; Hyaluronoglucosaminidase | 1957 |
Therapeutics and toxicology.
Topics: Anemia; Anemia, Pernicious; Antacids; Anti-Bacterial Agents; Arthritis; Arthritis, Rheumatoid; Blood Pressure; Cortisone; Dibenzylchlorethamine; Dicumarol; Epilepsy; Ergot Alkaloids; Heart Failure; Heparin; Histamine Antagonists; Humans; Hyaluronoglucosaminidase; Hydantoins; Hypersensitivity; Hypertension; Hyperthyroidism; Imidazoles; Iodine; Iodine Isotopes; Kidney; Meperidine; Mephenesin; Methadone; Motion Sickness; Norepinephrine; Organomercury Compounds; Peptic Ulcer; Tetraethylammonium; Therapeutics; Thiouracil; Thrombosis; Veratrum; Vitamin B 12 | 1950 |
Hyaluronidase limb-edema test on rat; a technique for investigations on permeability.
Topics: Animals; Edema; Heart Failure; Hyaluronoglucosaminidase; Permeability; Rats | 1951 |
[Possibilities of reducing of the area of myocardial infarction].
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Cardiac Glycosides; Heart Failure; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Nitroglycerin; Shock, Cardiogenic | 1977 |
From the NIH: Used early after attack, hyaluronidase protects heart muscle from blood-deprivation destruction.
Topics: Animals; Heart; Heart Failure; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Shock, Cardiogenic | 1979 |